Sanofi, Regeneron ready to file cemiplimab

14th December 2017 Uncategorised 0

Sanofi and Regeneron are gearing up to file their experimental PD-1 inhibitor cemiplimab on both sides of the Atlantic following the drug’s success in clinical trials.

More: Sanofi, Regeneron ready to file cemiplimab
Source: News